News
IXSBF
0.0001
NaN%
--
Weekly Report: what happened at IXSBF last week (0908-0912)?
Weekly Report · 09/15/2025 10:29
Weekly Report: what happened at IXSBF last week (0901-0905)?
Weekly Report · 09/08/2025 10:31
Weekly Report: what happened at IXSBF last week (0825-0829)?
Weekly Report · 09/01/2025 10:27
Weekly Report: what happened at IXSBF last week (0818-0822)?
Weekly Report · 08/25/2025 10:34
Weekly Report: what happened at IXSBF last week (0811-0815)?
Weekly Report · 08/18/2025 10:29
Weekly Report: what happened at IXSBF last week (0804-0808)?
Weekly Report · 08/11/2025 10:34
Weekly Report: what happened at IXSBF last week (0728-0801)?
Weekly Report · 08/04/2025 10:36
Weekly Report: what happened at IXSBF last week (0721-0725)?
Weekly Report · 07/28/2025 10:37
Weekly Report: what happened at IXSBF last week (0714-0718)?
Weekly Report · 07/21/2025 10:29
Weekly Report: what happened at IXSBF last week (0707-0711)?
Weekly Report · 07/14/2025 10:36
Weekly Report: what happened at IXSBF last week (0630-0704)?
Weekly Report · 07/07/2025 10:30
Weekly Report: what happened at IXSBF last week (0623-0627)?
Weekly Report · 06/30/2025 10:35
Weekly Report: what happened at IXSBF last week (0616-0620)?
Weekly Report · 06/23/2025 10:29
Weekly Report: what happened at IXSBF last week (0609-0613)?
Weekly Report · 06/16/2025 10:34
Weekly Report: what happened at IXSBF last week (0602-0606)?
Weekly Report · 06/09/2025 10:35
Weekly Report: what happened at IXSBF last week (0526-0530)?
Weekly Report · 06/02/2025 10:40
Weekly Report: what happened at IXSBF last week (0519-0523)?
Weekly Report · 05/26/2025 10:40
Weekly Report: what happened at IXSBF last week (0512-0516)?
Weekly Report · 05/19/2025 10:33
Weekly Report: what happened at IXSBF last week (0505-0509)?
Weekly Report · 05/12/2025 10:34
Weekly Report: what happened at IXSBF last week (0428-0502)?
Weekly Report · 05/05/2025 10:36
More
Webull provides a variety of real-time IXSBF stock news. You can receive the latest news about Innexus Biotech through multiple platforms. This information may help you make smarter investment decisions.
About IXSBF
InNexus Biotechnology Inc. (InNexus) is a development-stage company. The Company is a drug development company focused on commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology. InNexus is engaged in monetizing its technology for its own product development projects whether independently, through collaborations with strategic partners and/or through business development activities for the licensing and sale of its technologies and services. The Company focuses on developing and marketing DXL technology to the biotechnology and pharmaceutical community by launching and developing multiple product candidates. These candidates include potential therapeutic and diagnostic products. As of June 30, 2010, its products included DXL625, DXL702, DXL1218 and DXLr120 (CD20).